VC funding: Pliops, Returnly, Fortanix, Stateless, Aporeto

Pliops, Returnly, Fortanix, Stateless, Aporeto, among others, have announced their latest VC funding rounds.
VC funding in technology cos

Pliops

Pliops, a cloud storage solutions company, has received a $30 million Series B funding led by SoftBank Ventures Asia, with participation from all Series A investors including Intel Capital, State of Mind Ventures and Viola Ventures, along with strategic investors Western Digital Capital and Xilinx. The round brings the total invested in Pliops to date to $40 million, including the October 2017 Series A funding of $10 million.

Returnly

Returnly, the post-purchase payments company for retailers and brands, has raised $8 million in Series A funding — led by inside investors Mundi Ventures and The Venture City, with participation from Novel TMT Ventures and CoVenture.

Fortanix

Fortanix, an encryption technology company, has closed a $23 million Series B round of funding led by Intel Capital with the participation from existing investors Foundation Capital and Neotribe. The funding brings the company’s total funding to $31 million.

Stateless

Stateless, a network connectivity company, has raised $11.33 million in Series A funding led by Drive Capital with participation from existing investor Speedinvest.

Aporeto

Aporeto, a security company, announced $20 million in Series B funding — led by Comcast Ventures and several strategic and financial investors with the participation of existing investors Wing VC and Norwest Venture Partners.

Simplus

Simplus has raised $20 million led by Kensington – SV Global Innovations LP (KSV) and joined by Savano Capital Partners. Existing investors Salesforce Ventures, Cross Creek Advisors, EPIC Ventures, University Growth Fund, Simplus CFO Paul Fletcher and G2 Crowd CEO Godard Abel, also participated in the round.

Climb

Climb, a FinTech company that provides financing for students, has raised an additional $50 million in lending capital from the Goldman Sachs Urban Investment Group.